MediciNova
MNOV
#9504
Rank
C$0.10 B
Marketcap
C$2.16
Share price
0.65%
Change (1 day)
-31.99%
Change (1 year)

Revenue for MediciNova (MNOV)

Revenue in 2025 (TTM): C$0.18 Million

According to MediciNova's latest financial reports the company's current revenue (TTM ) is C$0.18 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of C$1.32 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MediciNova from 2004 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$0.18 M
2024 N/A-100%
2023 C$1.32 M
2022 N/A-100%
2021 C$5.14 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A-100%
2013 C$6.39 M700.72%
2012 C$0.79 M
2011 N/A
2010 N/A
2009 N/A
2006 C$0.3 M-67.18%
2005 C$0.93 M58.97%
2004 C$0.58 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
C$82.08 B 44,145,696.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$65.65 B 35,308,543.45%๐Ÿ‡ซ๐Ÿ‡ท France
Alkermes
ALKS
C$2.10 B 1,130,174.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
C$23.17 B 12,463,588.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
C$77.87 B 41,881,340.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland